1. Home
  2. CPAC vs TYRA Comparison

CPAC vs TYRA Comparison

Compare CPAC & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • TYRA
  • Stock Information
  • Founded
  • CPAC 1949
  • TYRA 2018
  • Country
  • CPAC Peru
  • TYRA United States
  • Employees
  • CPAC N/A
  • TYRA N/A
  • Industry
  • CPAC Building Materials
  • TYRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • TYRA Health Care
  • Exchange
  • CPAC Nasdaq
  • TYRA Nasdaq
  • Market Cap
  • CPAC 436.7M
  • TYRA 422.6M
  • IPO Year
  • CPAC 2012
  • TYRA 2021
  • Fundamental
  • Price
  • CPAC $5.50
  • TYRA $10.04
  • Analyst Decision
  • CPAC Sell
  • TYRA Strong Buy
  • Analyst Count
  • CPAC 1
  • TYRA 6
  • Target Price
  • CPAC $6.00
  • TYRA $30.50
  • AVG Volume (30 Days)
  • CPAC 7.0K
  • TYRA 359.8K
  • Earning Date
  • CPAC 05-02-2025
  • TYRA 05-08-2025
  • Dividend Yield
  • CPAC 9.20%
  • TYRA N/A
  • EPS Growth
  • CPAC 17.75
  • TYRA N/A
  • EPS
  • CPAC 0.12
  • TYRA N/A
  • Revenue
  • CPAC $524,464,683.00
  • TYRA N/A
  • Revenue This Year
  • CPAC N/A
  • TYRA N/A
  • Revenue Next Year
  • CPAC N/A
  • TYRA N/A
  • P/E Ratio
  • CPAC $9.25
  • TYRA N/A
  • Revenue Growth
  • CPAC 1.44
  • TYRA N/A
  • 52 Week Low
  • CPAC $5.10
  • TYRA $6.42
  • 52 Week High
  • CPAC $6.65
  • TYRA $29.60
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 47.88
  • TYRA 57.42
  • Support Level
  • CPAC $5.40
  • TYRA $7.80
  • Resistance Level
  • CPAC $5.60
  • TYRA $10.44
  • Average True Range (ATR)
  • CPAC 0.23
  • TYRA 0.74
  • MACD
  • CPAC 0.01
  • TYRA 0.36
  • Stochastic Oscillator
  • CPAC 60.61
  • TYRA 90.05

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: